CGON
CG Oncology, Inc.
72.61
-0.03 (-0.04%)
52w low 37.01
80.97 high
81.0% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Total Revenue | -- | 0.00 | 1.67M | 2.32M | 1.08M | 1.16M | |
| Cost of Revenue | -- | 0.00 | 1.58M | 3.07M | 2.96M | 3.92M | |
| Gross Profit | -- | 0.00 | 89.00K | -748.00K | -1.88M | -2.77M | |
| Operating Expenses | -- | 48.74M | 51.22M | 47.95M | 64.51M | 83.63M | |
| R&D | -- | 31.33M | 27.88M | 29.96M | 43.73M | 54.66M | |
| SG&A | -- | 17.41M | 23.33M | 17.99M | 20.78M | 28.98M | |
| Operating Income | -- | -48.74M | -51.13M | -48.70M | -66.39M | -86.40M | |
| EBITDA | -- | -48.59M | -50.71M | -47.85M | -65.55M | -85.55M | |
| Pretax Income | -- | -41.43M | -43.81M | -41.31M | -60.20M | -79.06M | |
| Net Income | -- | -41.43M | -43.81M | -41.31M | -60.20M | -79.06M | |
| EPS Diluted | -0.45 | -0.54 | -0.57 | -- | -0.71 | -0.90 | |
| Diluted Shares | 76.19M | 76.23M | 76.73M | -- | 84.52M | 88.20M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+6.8%